← Back to Patent Explorer
US4642295A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods of determining fructosamine levels in blood samples

Assignee: Roche Diagnostics Corp
•
Filing: 1982-12-15
•
Granted: 1987-02-10
•
Expires: 2002-12-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The determination of fructosamine levels in at least part of a blood sample for use in detecting diabetes in patients or deciding treatment levels is effected by controlling the temperature and pH of the sample, adding a coloring agent such as a nitro-blue tetrazolium and after a first delay in time taking a first color measurement at a predetermined wavelength and after a second delay in time taking a second color measurement at the predetermined wavelength, then comparing any resultant change between the first and second color measurements with those of standard solutions, the selected timing delays, wavelength, coloring agent and pH conditions being such that any change of color in the coloring agent between the first and second color measurements is caused predominantly by the glucose in the sample that is reacted with an amine group of protein and has undergone a molecular rearrangement to form fructosamine and not materially by any non-specific reducing substance which may be present in the sample.

Inventors

  • 👤 John R. Baker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 11:41
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/66; Y; Y10; Y10S; Y10S436/00; Y10S436/904; Y10T; Y10T436/00; Y10T436/10; Y10T436/104998; Y10T436/105831; Y10T436/14; Y10T436/142222; Y10T436/143333; Y10T436/144444

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 202 words
A method of determining the level of fructosamine in a blood sample or sample derived from blood wherein the level of fructosamine reflects an average serum glucose level in the sample over a period of time, said method comprising the steps of maintaining the sample at a controlled temperature below 5° C., controlling the pH of the sample to a value between 10 and 11, adding a colouring agent to the sample and after a first delay in time taking a first colour measurement at a predetermined wavelength and after a second delay in time taking a second colour measurement at the predetermined wavelength and determining the fructosamine level in said sample by comparing any resultant change between said first and second colour measurements with those of standard solutions wherein the colouring agent, timing of the delays wavelength and pH conditions selected such that any change of colour in the colouring agent between said first and second colour measurements is caused predominantly by glucose in the sample that is reacted or associated with an amine group of protein and has undergone a molecular re-arrangement to form fructosamine and not materially by any non-specific reducing substances which may be present in the sample.
Claim 2
Independent Claim 202 words
A method of determining the level of fructosamine in a blood sample or sample derived from blood wherein the level of fructosamine reflects an average serum glucose level in the sample over a period of time, said method comprising the steps of maintaining the sample at a controlled temperature below 5° C., controlling the pH of the sample to a value between 10 and 11, adding a colouring agent to the sample and after a first delay in time taking a first colour measurement at a predetermined wavelength and after a second delay in time taking a second colour measurement at the predetermined wavelength and determining the fructosamine level in said sample by comparing any resultant change between said first and second colour measurements with those of standard solutions wherein the colouring agent, timing of the delays wavelength and pH conditions selected such that any change of colour in the colouring agent between said first and second colour measurements is caused predominantly by glucose in the sample that is reacted or associated with an amine group of protein and has undergone a molecular re-arrangement to form fructosamine and not materially by any non-specific reducing substances which may be present in the sample.
Claim 3
Dependent Claim 33 words
The method as claimed in claim 1 which includes the step of calibrating a testing instrument used during testing of said sample using at least one testing standard which gives a known reading.
Claim 4
Dependent Claim 24 words
The method as claimed in claim 1 wherein said pH is controlled by adding to the sample a buffer which includes said colouring agent.
Claim 5
Dependent Claim 17 words
The method as claimed in claim 3 in which said buffer comprises sodium carbonate and sodium bicarbonate.
Claim 6
Dependent Claim 21 words
The method as claimed in claim 1 wherein said colouring agent comprises a tetrazolium salt which changes colour on being reduced.
Claim 7
Dependent Claim 14 words
The method as claimed in claim 5 wherein said colouring agent is nitro-blue tetrazolium.
Claim 8
Dependent Claim 24 words
The method as claimed in claim 1 wherein the method steps are carried out in an automatic testing apparatus on a series of samples.
Claim 9
Dependent Claim 21 words
The method as claimed in claim 7 wherein said series of samples are maintained at a temperature of about 45° C.
Claim 10
Dependent Claim 19 words
The method as claimed in claim 1 wherein said standard solutions comprise aqueous solutions of a protein and 1-deoxy-1-morpholinofructose.
Claim 11
Dependent Claim 12 words
The method as claimed in claim 9 wherein said protein is albumin.
Claim 12
Dependent Claim 37 words
The method as claimed in claim 1 wherein said first and second colour measurements are obtained by measuring colour absorbances at 530 nm 5-10 minutes and 8-15 minutes respectively after adding the colouring agent to the sample.
Claim 13
Dependent Claim 18 words
The method as claimed in claim 11 wherein the method steps are carried out at about 37° C.
Claim 14
Dependent Claim 28 words
The method as claimed in claim 11 wherein said colour absorbances are measured about 10 minutes and 15 minutes respectively after adding the colouring agent to the sample.
Claim 15
Independent Claim 184 words
A method of detecting diabetes mellitus by determining the level of fructosamine in a blood sample, comprising the steps of taking a blood sample, maintaining the sample at a controlled temperature below 50° C., controlling the pH of the sample to a value between 10 and 11, adding a colouring agent to the sample and after a first delay in time taking a first colour measurement at a predetermined wavelength and after a second delay in time taking a second colour measurement at the predetermined wavelength, obtaining corrected readings utilizing said colour measurements and comparing the corrected readings with corrected readings of standards representative of known stages of diabetes mellitus, wherein the colouring agent, timing of the delays, wavelength and pH conditions are selected such that any change of colour in the colouring agent between said first and second colour measurements is caused predominantly by glucose in the sample that is reacted or associated with an amine group of protein and has undergone a molecular re-arrangement to form fructosamine and not materially by any non-specific reducing substances which may be present in the sample.
Claim 16
Independent Claim 184 words
A method of detecting diabetes mellitus by determining the level of fructosamine in a blood sample, comprising the steps of taking a blood sample, maintaining the sample at a controlled temperature below 50° C., controlling the pH of the sample to a value between 10 and 11, adding a colouring agent to the sample and after a first delay in time taking a first colour measurement at a predetermined wavelength and after a second delay in time taking a second colour measurement at the predetermined wavelength, obtaining corrected readings utilizing said colour measurements and comparing the corrected readings with corrected readings of standards representative of known stages of diabetes mellitus, wherein the colouring agent, timing of the delays, wavelength and pH conditions are selected such that any change of colour in the colouring agent between said first and second colour measurements is caused predominantly by glucose in the sample that is reacted or associated with an amine group of protein and has undergone a molecular re-arrangement to form fructosamine and not materially by any non-specific reducing substances which may be present in the sample.
Claim 17
Dependent Claim 31 words
The method as claimed in claim 14 wherein said first and second colour measurements are taken at about 5 and 10 minutes respectively after adding said colouring agent to the sample.
Claim 18
Dependent Claim 15 words
The method as claimed in claim 14 wherein said colouring agent is a tetrazolium salt.
Claim 19
Dependent Claim 14 words
The method as claimed in claim 16 wherein said colouring agent is nitro-blue tetrazolium.

References Cited (Backward Citations)

FR1135880A Cited
US3682586A Cited
US4269605A Cited
US4200435A Cited
US4243534A Cited
US4268270A Cited
US4371374A Cited
US4407961A Cited
US4399227A Cited
US4409335A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-02-09 1990-08-11 1991-02-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-02-09 1994-08-11 1995-02-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-02-09 1998-08-11 1999-02-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag